Key result
PDE4D SNP56 polymorphism shows no association with ischemic stroke risk.
Why the study?
Is the PDE4D SNP56 polymorphism associated with an increased risk of ischemic stroke?
Meta-Analysis (n=19,487)
Is the PDE4D SNP56 polymorphism associated with an increased risk of ischemic stroke?
Odds Ratio: 1.01 (95% CI 0.88–1.15)
p-value: p=0.90
This meta-analysis found no significant association between the PDE4D SNP56 polymorphism and susceptibility to ischemic stroke in Asian or European populations.
Does not implicate PDE4D SNP56 in ischemic stroke risk; confirms null association and narrows genetic targets for future studies.
BACKGROUND Recent studies demonstrated that polymorphisms in the PDE4D gene were associated with several processes involved in the occurrence of ischemic stroke (IS). The association between specific PDE4D single-nucleotide polymorphism 56 (SNP56) and IS risk was initially identified via genome-wide association studies (GWAS), although the GWAS in different populations produced inconclusive results. Thus, we performed a meta-analysis to better explain the association between PDE4D SNP56 and IS risk. MATERIAL AND METHODS A literature search was conducted using PubMed, Embase, and Web of Science up to June 1, 2015. A fixed-effects or random-effects model was used to calculate the pooled odds ratios (ORs) based on the results from the heterogeneity tests. RESULTS Finally, we performed a meta-analysis of 15 studies, involving 8731 IS patients and 10,756 controls. The results showed nonsignificant association between PDE4D SNP56 and IS risk (T vs. A: OR=1.01, 95%CI=0.88-1.15, P=0.90). Similarly, in the subgroup analysis by ethnicity, no significant association was observed in Asian (T vs. A: OR=1.08, 95%CI=0.80-1.44, P=0.62) or European (T vs. A: OR=0.96, 95%CI=0.86-1.08, P=0.54) population. Moreover, funnel plots and Egger regression testing showed no evidence of publication bias. CONCLUSIONS In summary, current evidence suggested that PDE4D SNP56 might not be associated with an increased susceptibility to IS. However, this conclusion needs further validation by well-designed studies with large sample sizes.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2016) conducted a meta-analysis in Ischemic Stroke (n=19,487). PDE4D SNP56 (T vs. A allele) vs. A allele was evaluated on Ischemic stroke risk (OR 1.01, 95% CI 0.88-1.15, p=0.90). The PDE4D SNP56 polymorphism (T vs. A allele) was not significantly associated with the risk of ischemic stroke (OR 1.01; 95% CI 0.88-1.15; P=0.90).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: